Cath Bollard
Cath Bollard
Professor, The George Washington University
Verified email at
Cited by
Cited by
CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
B Savoldo, CA Ramos, E Liu, MP Mims, MJ Keating, G Carrum, ...
The Journal of clinical investigation 121 (5), 1822-1826, 2011
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
HE Heslop, KS Slobod, MA Pule, GA Hale, A Rousseau, CA Smith, ...
Blood, The Journal of the American Society of Hematology 115 (5), 925-935, 2010
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
AM Leen, GD Myers, U Sili, MH Huls, H Weiss, KS Leung, G Carrum, ...
Nature medicine 12 (10), 1160-1166, 2006
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
AM Leen, CM Bollard, AM Mendizabal, EJ Shpall, P Szabolcs, JH Antin, ...
Blood, The Journal of the American Society of Hematology 121 (26), 5113-5123, 2013
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
CRY Cruz, KP Micklethwaite, B Savoldo, CA Ramos, S Lam, S Ku, ...
Blood, The Journal of the American Society of Hematology 122 (17), 2965-2973, 2013
Cord-blood engraftment with ex vivo mesenchymal-cell coculture
M De Lima, I McNiece, SN Robinson, M Munsell, M Eapen, M Horowitz, ...
New England Journal of Medicine 367 (24), 2305-2315, 2012
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins
CM Bollard, S Gottschalk, V Torrano, O Diouf, S Ku, Y Hazrat, G Carrum, ...
Journal of Clinical Oncology 32 (8), 798, 2014
Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease
CM Bollard, L Aguilar, KC Straathof, B Gahn, MH Huls, A Rousseau, ...
The Journal of experimental medicine 200 (12), 1623-1633, 2004
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes
KCM Straathof, CM Bollard, U Popat, MH Huls, T Lopez, MC Morriss, ...
Blood 105 (5), 1898-1904, 2005
Adapting a transforming growth factor β–related tumor protection strategy to enhance antitumor immunity
CM Bollard, C Rössig, MJ Calonge, MH Huls, HJ Wagner, J Massague, ...
Blood, The Journal of the American Society of Hematology 99 (9), 3179-3187, 2002
Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes
CA Ramos, B Ballard, H Zhang, O Dakhova, AP Gee, Z Mei, M Bilgi, ...
The Journal of clinical investigation 127 (9), 3462-3471, 2017
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell …
AM Leen, A Christin, GD Myers, H Liu, CR Cruz, PJ Hanley, ...
Blood, The Journal of the American Society of Hematology 114 (19), 4283-4292, 2009
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States
JI Cohen, ES Jaffe, JK Dale, S Pittaluga, HE Heslop, CM Rooney, ...
Blood, The Journal of the American Society of Hematology 117 (22), 5835-5849, 2011
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
CM Bollard, S Gottschalk, AM Leen, H Weiss, KC Straathof, G Carrum, ...
Blood, The Journal of the American Society of Hematology 110 (8), 2838-2845, 2007
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)
A Younes, P Hilden, B Coiffier, A Hagenbeek, G Salles, W Wilson, ...
Annals of Oncology 28 (7), 1436-1447, 2017
T-cell therapy in the treatment of post-transplant lymphoproliferative disease
CM Bollard, CM Rooney, HE Heslop
Nature reviews Clinical oncology 9 (9), 510-519, 2012
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral …
PJ Hanley, CRY Cruz, B Savoldo, AM Leen, M Stanojevic, M Khalil, ...
Blood, The Journal of the American Society of Hematology 114 (9), 1958-1967, 2009
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma
CU Louis, K Straathof, CM Bollard, S Ennamuri, C Gerken, TT Lopez, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 33 (9), 983, 2010
Epstein-Barr virus–specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy
C Rossig, CM Bollard, JG Nuchtern, CM Rooney, MK Brenner
Blood, The Journal of the American Society of Hematology 99 (6), 2009-2016, 2002
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-β receptor
AE Foster, G Dotti, A Lu, M Khalil, MK Brenner, HE Heslop, CM Rooney, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 31 (5), 500, 2008
The system can't perform the operation now. Try again later.
Articles 1–20